ELEANORA MYERS: Open Payments
NPI 1265101141 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,492 in 85 payments from 15 companies in 2025. Trend: 2023 $332 · 2024 $1,134 · 2025 $1,492
Food & beverage: $1,492
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $384 |
| Madrigal Pharmaceuticals | 26 | $265 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $243 |
| Ardelyx, Inc. | 7 | $119 |
| Celltrion USA Inc. | 6 | $117 |
| GENZYME CORPORATION | 2 | $80 |
| Aimmune Therapeutics, Inc. | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
| QOL Medical, LLC | 2 | $38 |
| Ipsen Biopharmaceuticals, Inc | 2 | $33 |
Products named: REZDIFFRA, RINVOQ, ENTYVIO, DUPIXENT, IBSRELA, VEGZELMA, LINZESS, EOHILIA.
Industry payments across IN — which companies pay providers there.
